Satsuma Pharmaceuticals Inc (STSA) is lower by 1.90% Wednesday In Premarket Trading

Wednesday, April 26, 2023 08:25 AM | InvestorsObserver Analysts

Mentioned in this article

Satsuma Pharmaceuticals Inc (STSA) is lower by 1.90% Wednesday In Premarket Trading

Satsuma Pharmaceuticals Inc (STSA) is lower by Wednesday morning, with the stock losing -1.90% in pre-market trading to 1.03. STSA's short-term technical score of 16 indicates that the stock has traded less bullishly over the last month than 84% of stocks on the market. In the Biotechnology industry, which ranks 114 out of 146 industries, the stock ranks higher than 25% of stocks. Satsuma Pharmaceuticals Inc has risen 17.98% over the past month, closing at $0.77 on March 29. During this period of time, the stock fell as low as $0.66 and as high as $1.47. STSA has an average analyst recommendation of Buy. The company has an average price target of $2.00.

STSA has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on STSA!

See Full STSA Report

Satsuma Pharmaceuticals Inc has a Long-Term Technical rank of 53. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 47% of the market scoring higher. In the Biotechnology industry which is number 103 by this metric, STSA ranks better than 103% of stocks.

Important Dates for Investors in STSA:

-Satsuma Pharmaceuticals Inc is set to release earnings on 5/9/2023. Over the last 12 months, the company has reported EPS of $-2.20. -We do not have a set dividend date for Satsuma Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Satsuma Pharmaceuticals Inc (STSA)